Retrospective Analysis of Immune Checkpoint Inhibitors in Patients with EGFR Mutated Non-Small Cell Lung Cancer in a Japanese Cohort

被引：0
|
作者：
Yamada, T. [1 ]
Shiotsu, S. [2 ]
Tanimura, K. [1 ]
Harada, T. [3 ]
Kubota, Y. [4 ]
Takeda, T. T. [5 ]
Watanabe, S. [6 ]
Uchino, J. [1 ]
Takayama, K. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Kyoto, Japan
[2] Japanese Red Cross Kyoto Daiichi Hosp, Kyoto, Japan
[3] Fukuchiyama City Hosp, Fukuchiyama, Japan
[4] Japanese Red Cross Kyoto Daini Hosp, Kyoto, Japan
[5] Uji Tokushukai Med Ctr, Uji, Kyoto, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR mutation; immune checkpoint inhibitor;
D O I：
10.1016/j.jtho.2018.08.659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-102
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [41] Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer
    Shannon, Vickie R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 326 - 340
  • [42] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
  • [43] Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer
    Miura, Yosuke
    Kasahara, Norimitsu
    Sunaga, Noriaki
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S628 - S632
  • [44] Safety of current immune checkpoint inhibitors in non-small cell lung cancer
    Abdayem, Pamela
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 651 - 667
  • [45] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [46] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [47] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [48] Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer
    Uehara, Yuji
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 6 - 10
  • [49] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Zhenbin Qiu
    Zihao Chen
    Chao Zhang
    Wenzhao Zhong
    Experimental Hematology & Oncology, 8
  • [50] Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022,
12345